Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome

Last updated: May 29, 2022
Sponsor: Oslo University Hospital
Overall Status: Active - Enrolling

Phase

N/A

Condition

Retinitis Pigmentosa

Treatment

N/A

Clinical Study ID

NCT05400278
166639
  • Ages 16-80
  • All Genders

Study Summary

Bardet-Biedl syndrome (BBS; OMIN #209900) is a rare genetic disorder characterized by six core features: rod-cone dystrophy (retinitis pigmentosa), polydactyly, obesity, genital anomalies, renal anomalies, and learning difficulties. This study aims to contribute to genetic and medical knowledge of BBS, and to provide information on quality of life in adults with BBS and their close relatives. Participants will undergo medical assessments (ocular, oral, and physical examinations) and self-reporting of quality of life, diet, cognitive and emotional symptoms. There are some known genotype-phenotype associations in BBS and participants will be offered genetic testing. It is important to map both genotype and associated phenotype in order to provide optimal treatment and follow-up. Individuals with BBS, age 16 years or older, will be invited to participate. The investigators expect to enroll at least 25 male and female adults with BBS and 15 of their parents to participate in qualitative interviews. These interviews will investigate parents' experiences having a child with BBS, satisfaction with health care services, experience with social and family life, and psychological health.

Eligibility Criteria

Inclusion

Inclusion Criteria: Individuals diagnosed with BBS (see below), age 16 years or older. BBS is characterized bysix core features : rod-cone dystrophy (retinitis pigmentosa), polydactyly, obesity,genital anomalies, renal anomalies, and learning difficulties. Additional features include speech delay, developmental delay, diabetes mellitus, dentalanomalies, congenital heart disease, brachydactyly (shortening of fingers/toes), ataxia,and anosmia/hyposmia (deficienct sense of smell). A minimum of four of the core features,or three core features and two additional features are required for the clinical diagnosisof BBS.

Exclusion

Exclusion Criteria: Individuals age < 16 years, current severe illness or known diagnosis of autism.

Study Design

Total Participants: 40
Study Start date:
February 01, 2022
Estimated Completion Date:
December 31, 2026

Study Description

Improved care for adults with BBS living in Norway necessitates increased knowledge of pertinent health-related, emotional, and educational, employment and psychosocial issues. Adults with BBS living in Norway may face new challenges and have unmet healthcare needs. Therefore, the investigators intend to evaluate the adult with BBS as a person with special needs (e.g. need for support systems, lack of social opportunities, and mental health problems) and long-term challenges.This project will describe the visual, medical, physical, nutritional, and psychological difficulties experienced by people with BBS. The planned multi-disciplinary clinical evaluation in this study can help address the existing knowledge gaps. Relatives who help their loved ones with various activities of daily living may experience reduced quality of life and altered social roles. Therefore, the investigators also want to study the quality of life and psychological status of close relatives. This project might contribute information for new clinical protocols and suggest areas for further research in genetics, healthcare needs and quality of life for people living with BBS.

Connect with a study center

  • Oslo University Hospital

    Oslo, 0373
    Norway

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.